Drug Patent Expirations for the Week of December 4, 2022

VIIBRYD (vilazodone hydrochloride) Allergan Patent: 8,673,921 Expiration: Dec 5, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…

The post Drug Patent Expirations for the Week of December 4, 2022 appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.